The worldwide market for IVF (in vitro fertilization) devices and consumables is set for rapid growth, according to Precedence Research. Valued at USD 2.85 billion in 2024, the market is expected to rise steadily to USD 3.33 billion in 2025 and reach USD 13.51 billion by 2034.
North America currently leads this sector, generating USD 1 billion in 2024 and growing at a strong annual rate of 16.98% over the forecast period.
Key Drivers Behind Market Growth
The IVF market is expanding due to rising infertility rates worldwide and increased public awareness of fertility treatments. Advances in reproductive technology, such as cryopreservation and AI-based embryo selection, are also boosting demand.
Consumables like instruments, media, and reagents form the largest share of the market. Accessories and disposable products dominate because of their high usage and ongoing technological improvements.
Innovations such as time-lapse embryo imaging, AI-powered embryo selection tools, preimplantation genetic diagnosis, and cryopreservation methods have increased the success and appeal of IVF treatments.
Market Highlights
- Market value in 2024: USD 2.85 billion
- Projected value by 2034: USD 13.51 billion
- Expected compound annual growth rate (CAGR): 16.84% (2025–2034)
- North America holds 35% of the revenue share as of 2024
- Asia Pacific is forecasted to be a fast-growing region
Segment Insights
- IVF consumables accounted for 60% of market revenue in 2024.
- IVF devices are expected to grow significantly between 2025 and 2034.
- Assisted reproductive technology (ART) applications generated 75% of revenue in 2024.
- Time-lapse imaging technology is anticipated to see strong growth.
- Fertility clinics led end-users with 65% of revenue in 2024.
- Online sales channels are poised for significant expansion.
Recent Industry Developments
In December 2024, Astorg completed a takeover of Hamilton Thorne and acquired Cook Medical’s Reproductive Health business. Cook Medical’s portfolio includes ART consumables such as pipettes and catheters, while Hamilton Thorne provides precision instruments and related services. These companies will be rebranded under Astorg in 2025.
Emerging Trends
Automation is increasingly used to improve IVF accuracy and efficiency, with robotic platforms and automated equipment gaining popularity. Time-lapse embryo imaging is helping doctors select the best embryos, enhancing IVF success rates.
Delayed parenthood and rising maternal age, due to social factors like education and career planning, are increasing the demand for IVF treatments. Additionally, expanding insurance coverage and government funding are supporting market growth.
Artificial Intelligence in IVF
AI integration is improving embryo selection, personalizing treatments, and optimizing workflows. This technology enhances data analysis and overall patient experience, making IVF procedures more effective.
Market Opportunities
Affordable and more efficient IVF methods are expected to expand access to fertility treatments. Innovations that improve success rates and offer personalized care will drive further growth in the IVF devices and consumables market.
Challenges
Ethical concerns, such as embryo storage, surrogacy, and genetic screening, present obstacles to wider adoption. Complex regulations on product approvals and quality control also challenge manufacturers and providers.
Regional Outlook
North America remains the largest market due to high IVF treatment adoption, fueled by increased infertility rates and fertility awareness. Meanwhile, Asia Pacific is emerging as a fast-growing market.
Leading Companies
Key players in this sector include CooperSurgical, Vitrolife AB, Merck KGaA, Cook Medical, Irvine Scientific, Hamilton Thorne Ltd, and Thermo Fisher Scientific, among others.
Related topics:
